8-60hIPP5(m)-induced G2/M cell cycle arrest involves activation of ATM/p53/p21(cip1/waf1) pathways and delayed cyclin

Qi-Yan Zeng1, Lin-Jie Zeng, Yu Huang

  • 1Department of Biochemistry and Molecular Biology, Guangxi Medical University, Nanning, China

Insights

The active mutant 8-60hIPP5(m) inhibits human cervix carcinoma (HeLa) cell growth by inducing G2/M-phase arrest. This occurs through the ATM/p53/p21(cip1/waf1)/Cdc2/cyclin B1 pathway, revealing a novel cell cycle regulation role.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Protein phosphatase 1 (PP1) is crucial for gene expression and cell cycle control.
  • The inhibitory molecule 8-60hIPP5(m) has demonstrated potential in inhibiting human cervix carcinoma (HeLa) cell growth.

Purpose of the Study:

  • To elucidate the mechanisms by which 8-60hIPP5(m) inhibits HeLa cell growth.
  • To investigate the role of 8-60hIPP5(m) in cell cycle regulation.

Main Methods:

  • Overexpression of 8-60hIPP5(m) in HeLa cells.
  • Flow cytometry and biochemical analyses.
  • Co-precipitation assays to determine protein interactions.

Main Results:

  • Overexpression of 8-60hIPP5(m) induced G2/M-phase arrest in HeLa cells.
  • This arrest was linked to the upregulation of cyclin B1 and phosphorylation of ATM, p53, p21(cip1/waf1), and Cdc2.
  • 8-60hIPP5(m) delayed nuclear translocation of cyclin B1 and interacted with pp1α and Cdc2 in the nucleus.

Conclusions:

  • 8-60hIPP5(m) plays a novel role in regulating the cell cycle of HeLa cells.
  • The findings suggest potential therapeutic strategies for cervix carcinoma targeting these pathways.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.3K
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
5.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K